Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03443284 · ClinicalTrials.gov registry record · NA
Health Partner Evaluation at Providence
A NA study, sponsored by DePuy Orthopaedics.
- Terminated
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT03443284 is a NA study that was terminated before completion, run by DePuy Orthopaedics. The registered enrollment target is 79 participants.
The verdict
NCT03443284, a NA study, was terminated before completion, sponsored by DePuy Orthopaedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
This is a prospective, mixed methods, multi-center, randomized, comparative, controlled study. Providence Health \& Services will enroll a total of 296 subjects (18 years or older) who are electing to have total knee or hip replacement surgery. Subjects will be randomized to either the treatment group (Health Partner alongside standard care) or the control group (standard care alone). Health Partner is a combination of an iPhone or iPod Touch Operating System mobile application and a health care provider portal. The primary objective is to compare care plan adherence (pre- and post-surgery) for Health Partner vs. control subjects. Secondary objectives include evaluating all-cause medical resource utilization, communication with health care provider, well-being, fear of surgery, confidence in recovery from surgery, sleep, and patient satisfaction for 90 days post-surgery. To evaluate the behavioral factors associated with care path adherence using a qualitative interview method.To evaluate the usability and preferences of patients in their interaction with the intervention using a qualitative interview method, for product development. The total planned study duration is approximately 1 year and 7 months.
Interventions
- BEHAVIORAL Standard Care
- BEHAVIORAL Health Partner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2018-12-11 |
| Est. Completion | 2019-12-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03443284
The ClinicalTrials.gov registry entry for NCT03443284 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DePuy Orthopaedics, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.
NCT03443284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03443284 about?
NCT03443284 is a clinical study titled "Health Partner Evaluation at Providence". This is a prospective, mixed methods, multi-center, randomized, comparative, controlled study. Providence Health \& Services will enroll a total of 296 subjects (18 years or older) who are electing to have total knee or hip replacement surgery. Subjects will be randomized to either the treatment gro...
What is the current status of trial NCT03443284?
This trial is currently terminated. It is a NA study. The enrollment target is 79 participants. The study started on 2018-12-11. Estimated completion is 2019-12-17.
What interventions are being tested in trial NCT03443284?
The interventions under investigation include: Standard Care (BEHAVIORAL), Health Partner (BEHAVIORAL).
Who is sponsoring clinical trial NCT03443284?
This trial is sponsored by DePuy Orthopaedics, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.